Κυριακή 7 Δεκεμβρίου

Quality of Care and patient safety

C.1. Quality of Care and patient safety: principles

1. The role of standards and patient safety indicators

2. The role of staff training, competence and revalidation

3. Continuous Quality Improvement in PD

C.2. Quality of Care: policies

1. The CQC standards and policies for Dialysis Units

2. The UKKA KQI Program

3. The Greek national policy

4. The role of the Renal registries

Workshop on home therapies

W.1. Healthcare systems & policies

1. Achieving equity in dialysis care and outcomes: the role of policies

2. System-level strategies to improve home dialysis uptake

3. Τhe role of networks and business planning

W.2. Unmet needs

1. Point of care PD solution generation: can it make a difference?

2. Supporting the patient journey

3. Assisted PD and home HD: to whom and how?

W.3. Training session

1. Teach PD trial: training the nurses

2. ISPD patient teaching curriculum guidelines

3. EDTNA accreditation in nursing training

Γενική συνέλευση & εκλογές

Lunch break

W.4. Quality of life

1. Patient reported experience and outcome measures

2. Burden of treatment, social engagement and employment across different modalities

3. Empowering patients to get their voice heard: shared care, PREMs & PROMs, and beyond

W.5. Clinical outcomes

1. Cardiovascular outcomes across different modalities

2. Dialysis prescription and outcomes

3. Staff training and clinical outcomes

W.6. Dialysis prescription

1. Prescription modelling

2. Tailoring PD to membrane

3. Tailoring PD & HHD to body habitus and residual kidney function

Nursing

C.3. Nursing session

1. Protocols in haemodialysis

2. Dry weight assessment

3. Intradialytic BP disorders: assesment and management

Breakthrough in Nephrology

C.4. Challenging the status quo in CKD

1. SGLT2 inhibitors: update
2. The place of GLP-1 agonists in clinical practice

3. The place of MRA in clinical practice

C.5. Clinical Nephrology

1. Novel & emerging treatment in IgA nephropathy

2. How should I manage the patient with IgA nephropathy?

3. Novel biomarkers in AKI

Dietetics

C.6. Dietetic session

1. The place of diet in CKD management

2. IDPN: when, for whom, and how?

3. Guidelines for the protein requirements in chronic and acute PD